Posts Tagged ‘C’

THLD soars, C sells, ISPH stumbles

Monday, January 3rd, 2011

Threshold Pharmaceuticals Inc. (Nasdaq: THLD) started 2011 higher 34.08 percent in price Monday to $1.81. Volume of 49,432 shares closed in on its all-day average of 94,631. THLD, based in Redwood City, Calif., Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors.

Citigroup Inc. (NYSE: C) did a brisk business the first Monday after New Year, trading in 43,054,072 shares, making up ground on its daily average of 538,216,000. Prices for the stock pushed ahead 1.8 percent to $4.82, on announcing that on New Year’s Eve, C it had completed transactions with Discover Financial Services and SLM Corporation that resulted in the divestiture of its student loan business, The Student Loan Corporation.

Inspire Pharmaceuticals Inc. (Nasdaq: ISPH) listed downward Monday, losing 58.45 percent in price to $3.49, on volume of 6,848,880 shares, dwarfing a full-day average of 577,058. ISPH announced today the top-line results from its second Phase 3 clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis.

LEGC shakes a leg, C active, CAK backtracks

Wednesday, December 22nd, 2010

Legacy Bancorp Inc. (Nasdaq: LEGC) added 42.21 percent in price Wednesday to $12.23. Volume of 140,153 shares towered over its daily average of 5,931. The Pittsfield, Mass., bank-holding company will acquired by Berkshire Hills Bancorp Inc. for $13 a share in stock and cash.

Citgroup Inc. (NYSE: C) traded in 146,817,000 shares, making it a volume leader as it made progress against its daily average of 554,823,000. Share prices slid 0.74% to $4.70.

CAMAC Energy Inc. (Amex: CAK) gave back 24.24 percent in price Wednesday to $2.00, on volume of 2,872,639 shares, nearly six times its full-day average. The energy firm entered into definitive agreements yesterday to sell in a registered direct offering an aggregate of approximately 9.09 million shares of its common stock at a price of $2.20 per share.

ICGN moves upward, C busy, ULTR slips

Monday, December 20th, 2010

Icagen Inc. (Nasdaq: ICGN) vaulted 33.79 percent in price Monday to $1.94. Volume of 1,107,887 shares quadrupled its full-day average. The North Carolina-based drug company today provided an update on its sodium channel program for pain and related disorders, which is being conducted in collaboration with Pfizer.

Citigroup (NYSE: C) was a volume leader Monday, trading in 207,906,616 shares, making progress against its daily average of 556,140,000. Share prices for Citi eased 0.11 percent to $4.70. Citi today announced a multi-year renewal of its long-standing U.S. private label credit card partnership with The Children’s Place Retail Stores Inc., the largest pure-play children’s specialty apparel retailer in North America.

Ultrapetrol Ltd. (Nasdaq: ULTR) fell 13.95 percent Thursday to $6.45, on volume of 336,901 shares, five times its full-day average. Ultrapetrol announced today its intention to offer to sell, subject to market and other conditions, $60.0 million aggregate principal amount of its Convertible Senior Notes due 2017.

CO with healthy gain, C chugs, MSB suffers malaise

Thursday, December 16th, 2010

China Cord Blood Corporation (NYSE: CO) gained 13.12 percent in price Thursday to $3.62. Volume of 321,351 shares trumped its full-day average of 205,100. CO, the first and largest cord blood banking operator in China, today announced that the Company will hold its annual general meeting of record at the Company’s Hong Kong office on February 18, 2011

Citigroup, Inc. (NYSE: C) traded Thursday in 304,577,005 shares, rapidly catching up on its daily average of 544,597,000. Share prices lurched backward 0.65 per cent, to $4.56.

Mesabi Trust (NYSE: MSB) surrendered 13.47 percent Thursday to $46.00. Volume of 1,367,117 shares more than tripled its full day average. MSB is a stock, with various holding interests in iron ore properties.

CYPB spreads wings, C solid, MOTR in reverse

Wednesday, December 15th, 2010

Cypress Bioscience (NasdaqGM: CYPB) jumped 12.2% to$6.45, on volume of 8,570,704, or 16 times its full-day average, after it agreed to be acquired by Ramius LLC and Royalty Pharma for about $255 million in cash, ending a takeover battle that began in July.

Citigroup (NYSE: C) traded in 155,455,525 shares, making good headway on its daily average of 539,270,000 shares. Share prices retreated 0.53 per cent, however, Wednesday, to $4.66.

Motricity Inc. (NasdaqGM: MOTR) backtracked 13.53 percent in Wednesday morning trading at $18.40. Volume of 3,277,545 shares tramped its full-day average of 559,200. MOTR, based in Bellevue, Wash., is a leading mobile data solutions provider exclusively focused on the rapidly growing mobile Internet market.